Rifampicin at High Dose for Difficult-to-Treat Tuberculosis
Condition: Tuberculosis Intervention: Drug: Rifampin Sponsors: Hospital Universitari Vall d'Hebron Research Institute; University Medical Center Groningen; Radboud University; Centro Hospitalar De São João, E.P.E.; Instituto Nacional de Enfermedades Respiratorias y del Ambiente, Paraguay Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials